CLINICAL_TRIALS
trial_result
· 2026-04-06
Clinical Trial Update: Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
Summary
This clinical trial update reports results from a study examining peripheral T cell determinants of response and resistance to pembrolizumab in melanoma; the tr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Melanoma, Advanced Melanoma | Status: COMPLETED | Results posted: 2026-04-06